Vascular Dementia May Not Be Distinct Clinical Entity, FDA Cmte. Says
Vascular dementia may not be a distinct clinical entity that could be indicated in drug labeling, FDA's Peripheral & Central Nervous System Drugs Advisory Committee suggested.
Vascular dementia may not be a distinct clinical entity that could be indicated in drug labeling, FDA's Peripheral & Central Nervous System Drugs Advisory Committee suggested.